<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04946565</url>
  </required_header>
  <id_info>
    <org_study_id>TBA</org_study_id>
    <nct_id>NCT04946565</nct_id>
  </id_info>
  <brief_title>The Impact of Sinopharm COVID-19 Vaccination on Male Fertility</brief_title>
  <official_title>The Impact of Sinopharm COVID-19 Vaccination on Male Fertility of the Egyptian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators shall study the effect of Sinopharm vaccination on semen parameters and&#xD;
      serum testosterone&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators shall compare semen parameter (sperm density, sperm motility, and&#xD;
      percentage of abnormal sperm form) as well as morning serum testosterone before vaccination,&#xD;
      and 3 months after the second dose of the vaccine.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 3, 2021</start_date>
  <completion_date type="Anticipated">August 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sperm density count/ml</measure>
    <time_frame>up to 6 months</time_frame>
    <description>As measured from semen samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total sperm count per ejaculate</measure>
    <time_frame>up to 6 months</time_frame>
    <description>As measured from semen samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of motile sperm</measure>
    <time_frame>up to 6 months</time_frame>
    <description>As measured from semen samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of abnormal sperm forms</measure>
    <time_frame>up to 6 months</time_frame>
    <description>As measured from semen samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morning serum testosterone</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Total serum testosterone measured using immunoassay</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Male Infertility</condition>
  <condition>Hypogonadism, Male</condition>
  <arm_group>
    <arm_group_label>Sinopharm vaccine group</arm_group_label>
    <description>Participants scheduled to receive the Sinopharm vaccine will be evaluated on its effect on semen parameters for up to 6 months post vaccination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Semen analysis</intervention_name>
    <description>Semen analysis according to WHO laboratory manual for the examination and processing of human semen, Fifth edition</description>
    <arm_group_label>Sinopharm vaccine group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Men of reproductive age scheduled for COVID-19 Sinopharm Vaccine&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Receiving Sinopharm COVID-19 vaccines Male age 18-50 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults unable to consent&#xD;
&#xD;
          -  Men who have been receiving Testosterone replacement therapy or anabolic steroids&#xD;
             within the last year&#xD;
&#xD;
          -  Men with a history of male infertility&#xD;
&#xD;
          -  Men with a genetic or other medical condition known to be associated with decreased&#xD;
             semen parameters Positive COVID-19 PCR test within the 3 months&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Tarek H Anis, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Tarek H Anis, M.D.</last_name>
    <phone>+201222163858</phone>
    <email>tarekanis@kasralainy.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Islam Fathy, M.D.</last_name>
    <phone>+201004244360</phone>
    <email>islamandrology@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine, Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 28, 2021</study_first_submitted>
  <study_first_submitted_qc>June 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>July 3, 2021</last_update_submitted>
  <last_update_submitted_qc>July 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamed Tarek Anis</investigator_full_name>
    <investigator_title>Professor of Andrology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
    <mesh_term>Hypogonadism</mesh_term>
    <mesh_term>Eunuchism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

